EVENT – 18 APRIL 2018


Raising the value of your business


And why it makes sense, even if you never plan to sell

Debunk the myths of business valuation and learn how to build the value of your business – fast.


Businesses are frequently valued using the formula:


Valuation = Profit x Multiple


Of course, as business owners, we’re all too aware of how difficult it can be to grow Profit – it’s easier said than done, even in easier economic times.


But what about the Multiple part of the equation? Most would be led to believe that the Multiple is determined by the industry and therefore is fixed, and out of our control.


Assay challenge this theory to help you maximise the Multiple of your business by decreasing risk or increasing strategic assets, as well as improving profits.


How hard is Brexit going to hit your business?


As an extra, Assay introduce a clear picture of the implications that Brexit will potentially have on your businesses, plus the actions you can take now, to mitigate against these risks – allowing you to plan with greater confidence.


Uncertain times create greater risk and greater opportunity.

Register for this event here

Join us for this FREE morning session to explore the factors to accelerate the valuation of your business.


Date: April 18th | Time: 08.00 – 11.00


Location: Keltie LLP, No. 1 London Bridge, London, SE1 9BA


This event has been specifically designed for business owners and is FREE to attend




08.00 – 08.30 Arrivals/Breakfast

08.30 – 10.00 Valuation

10.00 – 10.15 Coffee

10.15 – 11.00 Brexit


Your Presenters


Phil Ives, Consulting Partner at Assay Advisory


Dan Farraway, Analyst at Assay Corporate Finance


About Assay Advisory


Assay Advisory helps you gain the highest valuation and plan for the sale of your business.


Assay Corporate Finance is a UK member of IMAP, the global network dedicated to creating value in the M&A mid-market, with 64 offices in 40 countries. IMAP is consistently ranked among the top six M&A advisors for mid-market transactions (Thomson Reuters).